MARKET

BFRGW

BFRGW

Bullfrog AI Holdings, Inc.
NASDAQ
0.1060
0.00
0.00%
Opening 09:30 06/30 EDT
OPEN
--
PREV CLOSE
0.1060
HIGH
--
LOW
--
VOLUME
0
TURNOVER
--
52 WEEK HIGH
0.7400
52 WEEK LOW
0.1000
MARKET CAP
--
P/E (TTM)
-0.1928
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BFRG last week (0622-0626)?
Weekly Report · 1d ago
Weekly Report: what happened at BFRG last week (0615-0619)?
Weekly Report · 06/22 10:31
BullFrog AI Increases CEO Pay Amid Governance Continuity
TipRanks · 06/15 23:07
BullFrog AI stockholders elect four directors at annual meeting
PUBT · 06/15 21:31
Weekly Report: what happened at BFRG last week (0608-0612)?
Weekly Report · 06/15 10:32
Weekly Report: what happened at BFRG last week (0601-0605)?
Weekly Report · 06/08 10:27
President Trump Says Meeting Scheduled With AI Companies Soon; They Are Coming To White House, Maybe Next Week
Benzinga · 06/05 17:55
BullFrog AI names John Stewart SVP commercial sales to lead growth push
PUBT · 06/02 12:01
More
About BFRGW
Bullfrog AI Holdings, Inc. is a technology-enabled drug development company. The Company is focused specifically on advanced artificial intelligence / machine learning (AI/ML) analysis of complex data in the advancement of medicine. The Company’s platform technology, bfLEAP, is an analytical AI/ML platform that is a potentially disruptive tool for the analysis of pre-clinical and/or clinical data sets, such as the robust pre-clinical and clinical trial data sets being generated in translational research and development and clinical trial settings. The platform can capture the genetic and physical characteristics of patients in an unbiased manner and contextualize them against other disparate data sources from patients. Its siRNA targets Beta2-spectrin in the treatment of human diseases, such as hepatocellular carcinoma (HCC), obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis. Mebendazole is focused on targeting Glioblastoma.

Webull offers Bullfrog AI Holdings, Inc. stock information, including NASDAQ: BFRGW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BFRGW stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BFRGW stock methods without spending real money on the virtual paper trading platform.